Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 2/20 | 0.41 |
| ▸ | CTRC | Q99895 | 2/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.37 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | CTSG | P08311 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15826171 | 0.87 | PRSS1 (0.39) | PRSS1CTRCF2ALDH1A1SLC2A1 | |
| SCHEMBL3185827 | 0.83 | PRSS1 (0.38) | PRSS1CTRCF2ALDH1A1SLC2A1 | |
| SCHEMBL3975877 | 0.77 | PRSS1 (0.38) | PRSS1CTRCF2SLC2A1 | |
| SCHEMBL1364944 | 0.75 | FAAH (0.34) | PRSS1CTRCF2 | |
| SCHEMBL8243272 | 0.73 | — | — | |
| SCHEMBL6884389 | 0.72 | — | — | |
| SCHEMBL3977462 | 0.72 | FAAH (0.38) | PRSS1CTRCF2ALDH1A1 | |
| SCHEMBL12532875 | 0.71 | ALDH1A1 (0.36) | PRSS1CTRCF2ALDH1A1SLC2A1 | |
| SCHEMBL12532888 | 0.71 | ALDH1A1 (0.36) | PRSS1CTRCF2ALDH1A1SLC2A1 | |
| SCHEMBL12532882 | 0.71 | ALDH1A1 (0.36) | PRSS1CTRCF2ALDH1A1SLC2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10385002-B2 | Process for making esters of 2-acetoxyalkanoic acids using a 3,6-dialkyl-1,4-dioxane-2,5-dione or poly-(alpha-hydroxyalkanoic acid) as a starting material | NATUREWORKS LLC (US) | 2019-08-20 | — | — | US | claimed |
| US-20180208537-A1 | PROCESS FOR MAKING ESTERS OF 2-ACETOXYALKANOIC ACIDS USING A 3,6-DIALKYL-1,4-DIOXANE-2,5-DIONE OR POLY-(ALPHA-HYDROXYALKANOIC ACID) AS A STARTING MATERIAL | NATUREWORKS LLC (US) | 2018-07-26 | — | — | US | claimed |
| EP-3110787-B1 | PROCESS FOR MAKING ESTERS OF 2-ACETOXYALKANOIC ACIDS USING A 3,6-DIALKYL-1,4-DIOXANE-2,5-DIONE OR POLY-(ALPHA-HYDROXYALKANOIC ACID) AS A STARTING MATERIAL | NATUREWORKS LLC (US) | 2018-04-11 | — | — | EP | claimed |
| US-20170066708-A1 | PROCESS FOR MAKING ESTERS OF 2-ACETOXYALKANOIC ACIDS USING A 3,6-DIALKYL-1,4-DIOXANE-2,5-DIONE OR POLY-(ALPHA-HYDROXYALKANOIC ACID) AS A STARTING MATERIAL | NATUREWORKS, LLC | 2017-03-09 | — | — | US | claimed |
| EP-3110787-A1 | PROCESS FOR MAKING ESTERS OF 2-ACETOXYALKANOIC ACIDS USING A 3,6-DIALKYL-1,4-DIOXANE-2,5-DIONE OR POLY-(ALPHA-HYDROXYALKANOIC ACID) AS A STARTING MATERIAL | NatureWorks LLC (US) | 2017-01-04 | — | — | EP | claimed |
| EP-2516413-B1 | PROCESS FOR PREPARING CYCLIC ESTERS COMPRISING UNSATURATED FUNCTIONAL GROUPS AND POLYESTERS PREPARED FROM SAME | EVONIK CORP (US) | 2016-04-13 | — | — | EP | claimed |
| WO-2015127374-A1 | PROCESS FOR MAKING ESTERS OF 2-ACETOXYALKANOIC ACIDS USING A 3,6-DIALKYL-1,4-DIOXANE-2,5-DIONE OR POLY-(ALPHA-HYDROXYALKANOIC ACID) AS A STARTING MATERIAL | NATUREWORKS LLC (US) | 2015-08-27 | — | — | WO | claimed |
| US-8399686-B2 | Process for preparing cyclic esters comprising unsaturated functional groups and polyesters prepared from same | EVONIK DEGUSSA CORPORATION (US) | 2013-03-19 | — | — | US | claimed |
| US-8323678-B2 | Implantable medical devices comprising poly[l-lactide-co-(3,6-dialkyl-1,4-dioxane-2,5-dione)] | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2012-12-04 | — | — | US | claimed |
| EP-2516413-A1 | PROCESS FOR PREPARING CYCLIC ESTERS COMPRISING UNSATURATED FUNCTIONAL GROUPS AND POLYESTERS PREPARED FROM SAME | Evonik Degussa Corporation (US) | 2012-10-31 | — | — | EP | claimed |
| US-20120004324-A1 | Process for Preparing Cyclic Esters Comprising Unsaturated Functional Groups and Polyesters Prepared From Same | EVONIK OPERATIONS GMBH (DE) | 2012-01-05 | — | — | US | claimed |
| US-20110270387-A1 | Implantable Medical Devices Comprising Poly[L-Lactide-Co-(3,6-Dialkyl-1,4-Dioxane-2,5-Dione)] | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2011-11-03 | — | — | US | claimed |
| WO-2011084466-A1 | PROCESS FOR PREPARING CYCLIC ESTERS COMPRISING UNSATURATED FUNCTIONAL GROUPS AND POLYESTERS PREPARED FROM SAME | SURMODICS PHARMACEUTICALS, INC. (US) | 2011-07-14 | — | — | WO | claimed |
| US-20210277275-A1 | CROSSLINKED COATINGS | STEVENS DAVID M (US) | 2021-09-09 | — | — | US | disclosed |
| EP-3333148-B1 | PROCESS FOR MAKING A 2-ACETOXYALKANOIC ESTER | NATUREWORKS LLC (US) | 2020-10-14 | — | — | EP | disclosed |
| US-10414714-B2 | Process for making esters of 2-acetoxyalkanoic acids using a 3,6-dialkyl-1,4-dioxane-2,5-dione or poly-(alpha-hydroxyalkanoic acid) as a starting material | NATUREWORKS LLC (US) | 2019-09-17 | — | — | US | disclosed |
| US-20060194071-A1 | Developer carrying member and development apparatus | CANON KABUSHIKI KAISHA (JP) | 2006-08-31 | — | — | US | disclosed |
| US-20050287484-A1 | Resin-coated carrier for electrophotographic developer | CANON KABUSHIKI KAISHA (JP) | 2005-12-29 | — | — | US | disclosed |
| WO-2005121207-A2 | POLYHYDROXYALKANOATE HAVING VINYL GROUP, ESTER GROUP, CARBOXYL GROUP, AND SULFONIC GROUP, AND METHOD OF PRODUCING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2005-12-22 | — | — | WO | disclosed |
| WO-2005121206-A2 | POLYHYDROXYALKANOATE HAVING VINYL GROUP, ESTER GROUP, CARBOXYL GROUP AND SULFONIC ACID GROUP, AND PRODUCTION METHOD THEREOF | CANON KABUSHIKI KAISHA (JP) | 2005-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170066708-A1 | PROCESS FOR MAKING ESTERS OF 2-ACETOXYALKANOIC ACIDS USING A 3,6-DIALKYL-1,4-DIOXANE-2,5-DIONE OR POLY-(ALPHA-HYDROXYALKANOIC ACID) AS A STARTING MATERIAL | HACL2, ADH1A, HAAO | PRSS1 2603/4885CTRC 1432/4885F2 1505/4885 |
| US-20120004324-A1 | Process for Preparing Cyclic Esters Comprising Unsaturated Functional Groups and Polyesters Prepared From Same | PHOSPHO1, CETP, SGMS1 | PRSS1 2848/4885CTRC 1282/4885F2 695/4885 |
| US-10385002-B2 | Process for making esters of 2-acetoxyalkanoic acids using a 3,6-dialkyl-1,4-dioxane-2,5-dione or poly-(alpha-hydroxyalkanoic acid) as a starting material | HACL2, ADH1A, HAAO | PRSS1 2603/4885CTRC 1432/4885F2 1505/4885 |
| US-10414714-B2 | Process for making esters of 2-acetoxyalkanoic acids using a 3,6-dialkyl-1,4-dioxane-2,5-dione or poly-(alpha-hydroxyalkanoic acid) as a starting material | HACL2, ADH1A, HAAO | PRSS1 2603/4885CTRC 1432/4885F2 1505/4885 |
| US-20180208537-A1 | PROCESS FOR MAKING ESTERS OF 2-ACETOXYALKANOIC ACIDS USING A 3,6-DIALKYL-1,4-DIOXANE-2,5-DIONE OR POLY-(ALPHA-HYDROXYALKANOIC ACID) AS A STARTING MATERIAL | HACL2, ADH1A, HAAO | PRSS1 2603/4885CTRC 1432/4885F2 1505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.